低剂量sorafenib促进肝癌侵袭转移潜能的机制研究
81101871
2011
H1820.肿瘤综合治疗
张伟
青年科学基金项目
副主任医师
天津医科大学
22万元
肝细胞癌;侵袭转移潜能;sorafenib
2012-01-01到2014-12-31
- 中英文摘要
- 结题摘要
- 结题报告
- 项目成果
- 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
| 序号 | 标题 | 类型 | 作者 |
|---|---|---|---|
| 1 | Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib | 期刊论文 | Wei Kai|Wang M|Zhang Wei|Mu Han|Song Tianqiang| |
| 2 | <span style="color: black; font-family:;" roman";font-size:12pt;"="" new="" times="">Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular | 期刊论文 | Zhao Gang|Wei Kai|Zhang Qingxiang|Ma Weiwei|Song Tianqiang|Wu Qiang|Zhang Ti|Kong Dalu|Li Qiang| |
| 3 | Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma. | 期刊论文 | Lu Lu|Zhang Wei|Sun Hui-Chuan| |
| 4 | Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. | 期刊论文 | Xiong, Yu-Quan|Zhu, Xiao-Dong|Xu, Hua-Xiang|Kong, Ling-Qun|Wu, Wei-Zhong|Wang, Lu|Song, Tian-Qiang|Li, Qiang|Tang, Zhao-You| |
查看更多信息请先登录或注册
